Chamber's Report Bemoans Biden's March-In Idea For Drug IP
The most powerful business lobbying group in the U.S. said that although the country ranked at the top of its annual International IP Index, the Biden administration's efforts to potentially use...To view the full article, register now.
Already a subscriber? Click here to view full article